Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Findings with cis-Z-clopenthixol in the treatment of acute mania and schizophrenia.

König P, Seifert T, Eberhardt G.

Pharmacopsychiatry. 1986 Nov;19(6):424-8.

PMID:
3797470
2.

Cis(Z)-clopenthixol and haloperidol in chronic schizophrenic patients--a double-blind clinical multicentre investigation.

Heikkilä L, Laitinen J, Vartiainen H.

Acta Psychiatr Scand Suppl. 1981;294:30-8.

PMID:
7041517
3.

Open multicentre trial of zuclopenthixol in mania and schizophrenia based on the AMDP scales.

Bobon D, Troisfontaines B, Kempeneers JL, Xhenseval B, Bourdouxhe S, Mirel J, Gilson H, Toussaint C, von Frenckell R, Pedersen V.

Acta Psychiatr Belg. 1986 Mar-Apr;86(2):152-76.

PMID:
2873713
4.

Open clinical study of cis(Z)-clopenthixol.

Sechter D, Caillard V, Cuche H, Deniker P.

Acta Psychiatr Scand Suppl. 1981;294:20-4.

PMID:
6951393
5.

Cis(Z)-clopenthixol and clopenthixol (Sordinol) in chronic psychotic patients. A double-blind clinical investigation.

Gravem A, Engstrand E, Guleng RJ.

Acta Psychiatr Scand. 1978 Nov;58(5):384-8.

PMID:
362830
6.
7.

A double-blind clinical investigation of cis(Z)-clopenthixol and clopenthixol in chronic schizophrenic patients.

Heikkilä L, Karsten D, Valli K.

Acta Psychiatr Scand Suppl. 1981;294:25-9.

PMID:
7041516
9.

Maintenance treatment of chronic schizophrenic patients. A study with the long-acting thioxanthene derivative, cis(Z)-clopenthixol decanoate-sordinol depot.

Dom R, De Mesmaecker L, van den Broucke M, van Hest T, Baro F.

Acta Psychiatr Scand. 1978 Apr;57(4):299-304.

PMID:
352094
10.

Acute functional psychoses: treatment with zuclopenthixol dihydrochloride ('Clopixol') tablets.

Bhattacharyya SN, Ghoshal J, Sharma SK, Halstead N, John B, Launer MA, Mukherjee PK, Zigmond AS.

Pharmatherapeutica. 1987;5(1):1-8.

PMID:
3602019
11.

Neuroleptic treatment of oligophrenic patients. A double-blind clinical multicentre trial of cis(Z)-clopenthixol and haloperidol.

Karsten D, Kivimäki T, Linna SL, Pollari L, Turunen S.

Acta Psychiatr Scand Suppl. 1981;294:39-45.

PMID:
7041518
12.

Clopenthixol decanoate and perphenazine enanthate in schizophrenic patients. A double-blind Nordic multicentre trial.

Ahlfors UG, Dencker SJ, Gravem A, Remvig J.

Acta Psychiatr Scand Suppl. 1980;279:77-91.

PMID:
6996426
13.

Clinical and pharmacokinetic evaluation of zuclopenthixol acetate in Viscoleo.

Balant LP, Balant-Gorgia AE, Eisele R, Reith B, Gex-Fabry M, Garrone G.

Pharmacopsychiatry. 1989 Nov;22(6):250-4.

PMID:
2575763
14.

The use of oral zuclopenthixol in the treatment of functional psychotic illness.

Bereen FJ, Harte FB, Maguire J, Singh AN.

Pharmatherapeutica. 1987;5(1):62-8.

PMID:
3602024
15.

A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia.

Götestam KG, Ljunghall S, Olsson B.

Acta Psychiatr Scand Suppl. 1981;294:46-53.

PMID:
7041519
16.

Serum levels of the isomers of clopenthixol in patients given cis(Z)-clopenthixol or cis(Z)/trans(E)-clopenthixol.

Aaes-Jørgensen T, Gravem A, Jørgensen A.

Acta Psychiatr Scand Suppl. 1981;294:70-7.

PMID:
6951396
17.

[Clinical experience with Cis-(Z-)Clopenthixol-Decanoate (Sordinol-Depot) (author's transl)].

Zmorski T, Unterrassner R.

Schweiz Rundsch Med Prax. 1979 Nov 27;68(48):1605-9. German. No abstract available.

PMID:
538008
18.

Acute psychotic disorders treated with 5% zuclopenthixol acetate in 'Viscoleo' ('Cisordinol-Acutard'), a global assessment of the clinical effect: an open multi-centre study.

Løwert AC, Rasmussen EM, Holm R, Almbjerg F, Calberg H, Joensen A, Nimb M, Baden H, Andersen E, Westergård T, et al.

Pharmatherapeutica. 1989;5(6):380-6.

PMID:
2687895
19.

Clopenthixol decanoate in the treatment of chronic schizophrenic in-patients.

Viswanathan R, Rajhkowa S.

Pharmatherapeutica. 1982;3(2):93-9.

PMID:
7100227

Supplemental Content

Support Center